High consumption
of industrialized food with high fat content is
generally associated with insulin resistance, which in turn causes
memory impairment and cognitive decline. Nicotinamide and ascorbic
acid are among the promising neuroprotective molecules; however, an
appreciable therapeutic activity necessitates the administration of
a large dose of either. Therefore, the study aimed to assess if loading
them in chitosan nanoparticles in doses 5–10 times lower than
the unencapsulated forms would achieve comparable therapeutic results.
Animals were fed a high-fat-high-fructose (HFHF) diet for 75 days.
The vitamins in their conventional form (100 mg/kg) and the nanoparticles
under investigation (10 and 20 mg/kg) were given orally concomitantly
with the diet in the last 15 days. The intake of HFHF diet for 75
days led to an insulin-resistant state, with memory impairment, which
was verified behaviorally through the object recognition test. This
was accompanied by significant reduction in brain insulin-like growth
factor 1 (IGF-1), increased acetylcholine esterase activity, increase
in the serotonin and dopamine turnover ratio, and increase in oxidative
stress and 8-OHdG, indicating cellular DNA fragmentation. Cellular
energy was also decreased, and immunohistochemical examination verified
the high immunoreactivity in both the cortex and hippocampus of the
brain. The administration of nanoparticulated nicotinamide or ascorbic
acid with a 10 times lesser dose than the unencapsulated forms managed
to reverse all aforementioned harmful effects, with an even lesser
immunoreactivity score than the unencapsulated form. Therefore, it
can be concluded that nicotinamide or ascorbic acid chitosan nanoparticles
can be recommended as daily supplements for neuroprotection in patients
suffering from insulin resistance after conduction of clinical investigations.